Skip to main content

Published locations for Three-drug regimen boosts progression-free survival in patients with relapsed CLL and adverse prognostic features

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Three-drug regimen boosts progression-free survival in patients with relapsed CLL and adverse prognostic features

User login

  • Reset your password
  • /content/three-drug-regimen-boosts-progression-free-survival-patients-relapsed-cll-and-adverse
  • /hematologynews/article/110311/cll/three-drug-regimen-boosts-progression-free-survival-patients
  • /oncologypractice/article/110311/cll/three-drug-regimen-boosts-progression-free-survival-patients
  • /hematology-oncology/article/110311/cll/three-drug-regimen-boosts-progression-free-survival-patients
  • /b-cell-lymphoma-icymi/article/110311/cll/three-drug-regimen-boosts-progression-free-survival